Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Select Drug Profiles
New ADA-EASD Position Statement on Managing Hyperglycemia in Type 2 Diabetes favors Individualized Approach
Wayne Kuznar
Read More
Mounting Evidence that DPP-4 Inhibitors may Reduce Cardiovascular Risk
Wayne Kuznar
Read More
Management of Multiple Sclerosis: Building Consensus between Healthcare Providers and Payers
John A. Welz, MPH
Read More
Original Research
National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare and Medical Professional Liability Costs
Betsy J Lahue, MPH
,
Bruce S. Pyenson, FSA, MAAA
,
Kosuke Iwasaki, FIAJ, MAAA
,
Helen Blumen, MD, MBA
,
Susan Forray, FCAS, MAAA
,
Jeffrey M. Rothschild, MD, MPH
Stakeholder Perspective
by
Jaan Sidorov, MD, MHSA
Read More
In the News
Management of the Multiple Sclerosis Category: An Increasing Focus for Payers
Read More
In the News
Achieving Consensus between Healthcare Providers and Payers
Read More
In the News
Treating Multiple Sclerosis: The Healthcare Provider Perspective
Read More
In the News
Management of Multiple Sclerosis: Building Consensus between Healthcare Providers and Payers Overview
John A. Welz, MPH
Read More
In the News
Multiple Sclerosis Disease State Review
Read More
Perspectives
Interesting Times Ahead: Payers’ Innovation in the Era of Healthcare Reform
Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
186
187
188
189
190
191
192
Page 189 of 244
Results 1881 - 1890 of 2438
